Iovance Biotherapeutics
IOVA
#3883
Rank
โ‚น295.83 B
Marketcap
โ‚น639.42
Share price
-5.61%
Change (1 day)
219.00%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2026 (TTM): -โ‚น27.08 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2025 the company made an earning of -โ‚น36.91 Billion a decrease over its 2024 earnings that were of -โ‚น36.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น27.08 Billion-26.64%
2025 -โ‚น36.91 Billion0.74%
2024 -โ‚น36.64 Billion-14.17%
2023 -โ‚น42.69 Billion15.46%
2022 -โ‚น36.97 Billion16.39%
2021 -โ‚น31.76 Billion30.83%
2020 -โ‚น24.28 Billion26.62%
2019 -โ‚น19.18 Billion61.29%
2018 -โ‚น11.89 Billion38.09%
2017 -โ‚น8.61 Billion73.16%
2016 -โ‚น4.98 Billion92.7%
2015 -โ‚น2.58 Billion131.17%
2014 -โ‚น1.12 Billion-51.71%
2013 -โ‚น2.32 Billion6291.81%
2012 -โ‚น36.16 Million
2008 -โ‚น5.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-99.27% Bahamas
NRC Health
NRC
โ‚น1.37 B-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA